<html>
<head>
  <title>Gen3 Open Links</title>

  <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
  <meta http-equiv="Content-Security-Policy" 
    content="default-src 'none'; 
    img-src 'self' data: https://www.google-analytics.com; 
    script-src 'self' https://www.google-analytics.com; 
    style-src 'self' https://fonts.googleapis.com; 
    object-src 'none'; 
    worker-src 'self';
    connect-src 'self';
    font-src 'self' https://fonts.googleapis.com https://fonts.gstatic.com"
    >
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />

  <link href="./app.css" rel="stylesheet" />

</head>
<body>
  <header>
    <div class="row">
      <div class="logo-row">
        <img src="./blood-pac.img" alt="logo" class="logo"></img>
      </div>
    </div>
  </header>
  <h1>Treatment response and tumor evolution: Lessons from an extended series of multi-analyte liquid biopsies in a metastatic breast cancer patient<h1>
  <h2>Abstract</h2>

  <p>Currently, clinical characterization of metastatic breast cancer is based on tissue samples taken at time of diagnosis. However, tissue biopsies are invasive and tumors are continuously evolving, which indicates the need for minimal invasive longitudinal assessment of the tumor. Blood-based liquid biopsies provide minimal invasive means for serial sampling over the course of treatment and the opportunity to adjust therapies based on molecular markers. Here, we aim to identify cellular changes that occur in breast cancer over the lifespan of an affected patient through single-cell proteomic and genomic analysis of longitudinally sampled solid and liquid biopsies. Three solid and 17 liquid biopsies from peripheral blood of an ER+/HER2- metastatic breast cancer patient collected over 4 years and 8 treatment regimens were analyzed for morphology, protein expression, copy number alterations and single nucleotide variations. Analysis of 563 single morphometrically similar circulating tumor cells (CTCs) and 13 cell-free DNA (cfDNA) samples along with biopsies of the primary and metastatic tumor revealed progressive genomic evolution away from the primary tumor profiles, along with changes in ER expression and the appearance of resistance mutations. Both the abundance and the genomic alterations of CTCs and cfDNA were highly correlated and consistent with genomic alterations in the tissue samples. We demonstrate that genomic evolution and acquisition of drug resistance can be detected in real time and at single-cell resolution through liquid biopsy analytes and highlight the utility of liquid biopsies to guide treatment decisions.</p>

  <table class="dcf-table dcf-table-responsive dcf-table-bordered dcf-table-striped dcf-w-100%">
	<tbody>
		<tr>
			<td>Authors</td>
			<td><span>Lisa Welter<sup>1</sup>, Liya Xu<sup>1</sup>, Dillon McKinley<sup>1</sup>, Angel E. Dago<sup>2</sup>, Sara Restrepo-Vassalli<sup>1</sup>, Kevin Xu<sup>1,</sup> Mariam Rodriguez-Lee<sup>1</sup>, Anand Kolatkar<sup>1</sup>, Rafael Nevarez<sup>1</sup>, Rishvanth Kaliappan Prabakar<sup>1</sup>, Carmen Ruiz<sup>1</sup>, Jorge Nieva<sup>3</sup>, Peter Kuhn<sup>1,3,4</sup>, James Hicks<sup>1</sup></span></td>
		</tr>
		<tr>
			<td>Affiliations</td>
			<td><span>1. Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA, USA,<br> 2. The Scripps Research Institute, La Jolla, CA, USA,<br> 3. Keck School of Medicine, University of Southern California, Los Angeles, USA,<br>
4. Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA</span></td>
		</tr>
		<tr>
			<td>Journal</td>
			<td>Cold Spring Harbor Molecular Case Studies</td>
		</tr>
		<tr>
			<td>Publication URL</td>
			<td>http://molecularcasestudies.cshlp.org/</td>
		</tr>
		<tr>
			<td>Data Availability Date</td>
			<td></td>
		</tr>
		<tr>
			<td>Brief Description of Data Available</td>
			<td>low-pass copy number alternation (CNA) data from single cells and cell-free DNA (cfDNA), targeted sequencing of cfDNA, whole-exome sequencing and Sanger sequencing of the primary breast tissue and metastatic bone and liver biopsies, single-cell Sanger sequencing</td>
		</tr>
		<tr>
			<td>Sponsors/Acknowledgements</td>
			<td></td>
		</tr>
		<tr>
			<td>Study number/codes</td>
			<td></td>
		</tr>
		<tr>
			<td>Condition</td>
			<td>Metastatic Breast Cancer</td>
		</tr>
		<tr>
			<td>Study Type</td>
			<td></td>
		</tr>
		<tr>
			<td>Websites</td>
			<td></td>
		</tr>
	</tbody>
</table>
  <h2>Open Access Links</h2>
  <p>
      Open access data (with authz set to "*") can download without authentication.
  </p>

  <button type="button" data-gen3-did="0a2ea71e-6f43-4588-8703-361cfe67add4" class="g3-button_action">File1.zip</button>
  <br>
  <button type="button" data-gen3-did="0a2ea71e-6f43-4588-8703-361cfe67add4" class="g3-button_action">File2.zip</button>
  <br>
  <button type="button" data-gen3-did="0a2ea71e-6f43-4588-8703-361cfe67add4" class="g3-button_action">File3.zip</button>
  <br>
  <button type="button" data-gen3-did="0a2ea71e-6f43-4588-8703-361cfe67add4" class="g3-button_action">File4.zip</button>
  <br>
  <button type="button" data-gen3-did="0a2ea71e-6f43-4588-8703-361cfe67add4" class="g3-button_action">File5.zip</button>
  <br>
  <button type="button" data-gen3-did="0a2ea71e-6f43-4588-8703-361cfe67add4" class="g3-button_action">File6.zip</button>

  <script src="./download-helper.js"></script>
</body>
</html>
